programmed death ligand 1 trang 1 tải miễn phí từ TAILIEUCHUNG

"programmed death ligand 1" trang 1 - tải miễn phí từ Tailieuchung

Increase of soluble programmed cell death ligand 1 in patients with chronic hepatitis C

Increase of soluble programmed cell death ligand 1 in patients with chronic hepatitis C

9 46 0

Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: A case report

Programmed cell death-1 blockade in kidney carcinoma may induce eosinophilic granulomatosis with polyangiitis: A case report

6 14 1

Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PDL1) production and transport in colon cancer stem cells

Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PDL1) production and transport in colon cancer stem cells

12 45 1

Evaluation of membrane and soluble PD-L1 expression in advanced stage non-small cell lung cancer patients

Evaluation of membrane and soluble PD-L1 expression in advanced stage non-small cell lung cancer patients

9 7 1

Nivolumab plus ipilimumab versus nivolumab in individuals with treatmentnaive programmed death-ligand 1 positive metastatic soft tissue sarcomas: A multicentre retrospective study

Nivolumab plus ipilimumab versus nivolumab in individuals with treatmentnaive programmed death-ligand 1 positive metastatic soft tissue sarcomas: A multicentre retrospective study

8 40 1

Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma

Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma

10 63 1

Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies

Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma – correlation with clinicopathological data and comparison of antibodies

10 61 1

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

11 25 1

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer

9 25 1

Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: A meta-analysis

Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: A meta-analysis

11 36 1

Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma

Serum levels of soluble programmed death-ligand 1 (sPD-L1) in patients with primary central nervous system diffuse large B-cell lymphoma

11 75 1

Immune checkpoint inhibitors-related myocarditis in patients with cancer: An analysis of international spontaneous reporting systems

Immune checkpoint inhibitors-related myocarditis in patients with cancer: An analysis of international spontaneous reporting systems

9 28 1

The prognostic and clinicopathological significance of PD-L1 expression in patients with diffuse large B-cell lymphoma: A metaanalysis

The prognostic and clinicopathological significance of PD-L1 expression in patients with diffuse large B-cell lymphoma: A metaanalysis

12 40 1

PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma

PD-L1 and PD-L2 expression in the tumor microenvironment including peritumoral tissue in primary central nervous system lymphoma

12 65 0

Expression and clinical significance of PDL1 and BRAF expression in nasopharyngeal carcinoma

Expression and clinical significance of PDL1 and BRAF expression in nasopharyngeal carcinoma

8 51 0

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer

9 50 1

Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice

Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice

13 31 1

Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation

Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation

13 43 1

Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: A meta-analysis

Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: A meta-analysis

10 60 1

The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma

The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma

12 54 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.